GO:0035667 TRIF-dependent toll-like receptor 4 signaling pathway: Innate Immune Signaling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035667 describes the branch of TLR4 signaling that uses the adaptor TRIF (TICAM1) instead of MyD88, and is best known for driving IRF3-dependent type I interferon and delayed NF-kB responses after LPS sensing.
• TRIF-dependent TLR4 signaling requires receptor internalization into endosomes, a trafficking step controlled by CD14 and influenced by membrane lipid composition such as sphingomyelin synthase activity.
• The pathway can be selectively engaged: a synthetic TLR4 agonist can activate TRIF-dependent signaling without MyD88, showing the two branches are separable and druggable.
• Small-molecule modulators and natural compounds such as CDr10b and andrographolide suppress TRIF-dependent signaling by targeting nodes such as TBK1, making the pathway a pharmacological target.
• TRIF-dependent signaling is implicated in neuroinflammation and brain injury after subarachnoid hemorrhage, and in trained immunity programs in macrophages.
• CRISPR knockout, knock-in, point-mutation and overexpression cell models allow causal dissection of TRIF-dependent TLR4 signaling genes in a clean genetic background.
Description
GO:0035667, the TRIF-dependent toll-like receptor 4 signaling pathway, is a biological process in which ligand binding to TLR4 triggers intracellular signaling through the adaptor TRIF (also called TICAM1) rather than the canonical MyD88 adaptor. TLR4 is a pattern recognition receptor that detects bacterial lipopolysaccharide (LPS), and the TRIF branch is classically associated with endosomal signaling, IRF3 activation and production of type I interferons and delayed pro-inflammatory mediators. Because the MyD88 and TRIF arms can be genetically and pharmacologically separated, this GO term provides a precise framework for studying how innate immune cells decode LPS into distinct transcriptional programs. For researchers, GO:0035667 matters because it defines a discrete signaling module that can be perturbed without abolishing all TLR4 responses. Selective TRIF-dependent activation has been demonstrated with a synthetic TLR4 agonist, and small molecules can bias or suppress this arm. The pathway also intersects with membrane trafficking and lipid metabolism, since CD14-dependent internalization and sphingomyelin synthase activity affect TRIF-dependent signaling. These features make GO:0035667 a useful annotation target for studies of inflammation, host defense, neuroinflammation and immunomodulation.
TRIF-dependent toll-like receptor 4 signaling pathway At A Glance
| GO ID | GO:0035667 |
|---|---|
| GO term | TRIF-dependent toll-like receptor 4 signaling pathway |
| Ontology | biological_process |
| Synonym | Toll/IL-1 receptor (TIR) domain-containing adaptor-dependent TLR4 signaling pathway; TRIF-dependent TLR4 signaling pathway; TRIF-dependent toll-like receptor 4 signalling pathway |
| Major function | Transduces LPS-initiated TLR4 signals through the TRIF adaptor to activate IRF3 and NF-kB-dependent inflammatory and interferon responses |
| Key adaptor | TRIF (TICAM1), which defines the pathway and distinguishes it from MyD88-dependent TLR4 signaling |
| Upstream trigger | Bacterial lipopolysaccharide (LPS) binding to TLR4, with CD14-dependent trafficking to endosomes |
| Representative outputs | Type I interferon and delayed pro-inflammatory gene expression |
| Pharmacological relevance | Modulated by synthetic TLR4 agonists and small-molecule inhibitors such as CDr10b and andrographolide |
What Is GO:0035667?
In plain terms, GO:0035667 is the series of molecular signals that begins when a ligand such as LPS binds TLR4 and is transmitted inside the cell by the TRIF adaptor. It is a biological process annotation that specifically excludes MyD88-mediated transduction and instead captures the TRIF-dependent route, which is linked to endosomal signaling, IRF3 activation and interferon-related outputs.
Why Is TRIF-dependent toll-like receptor 4 signaling pathway Important in Cell Biology?
GO:0035667 is important because it defines the TRIF-dependent arm of TLR4 signaling, a branch that shapes the balance between immediate MyD88-driven inflammation and delayed interferon-associated responses. This distinction is experimentally actionable: selective TRIF-dependent signaling can be triggered by a synthetic TLR4 agonist, and the pathway can be suppressed by compounds targeting TBK1 or other nodes. Because TRIF-dependent signaling depends on receptor trafficking and membrane environment, it also connects innate immunity to lipid metabolism and endosomal biology. These properties make the pathway relevant to inflammatory disease, neuroinflammation and immunomodulation research.
• Defines a genetically separable TLR4 branch that can be studied independently of MyD88.
• Controls IRF3-dependent type I interferon and delayed inflammatory outputs after LPS sensing.
• Depends on CD14-mediated TLR4 internalization and endosomal trafficking.
• Is sensitive to membrane lipid composition, including sphingomyelin synthase activity.
• Can be selectively activated by synthetic TLR4 agonists, enabling biased signaling studies.
• Is a target of small-molecule modulators and natural-product inhibitors.
• Is implicated in neuroinflammation and brain injury after subarachnoid hemorrhage.
• Contributes to trained immunity programs in macrophages alongside MyD88-dependent signals.
• Provides a tractable module for CRISPR-based causal gene studies in immune cells.
What Happens During TRIF-dependent toll-like receptor 4 signaling pathway?
LPS sensing and receptor engagement
In simple terms: The pathway starts when bacterial LPS is recognized by TLR4 on the cell surface.
TLR4 is a pattern recognition receptor that binds bacterial lipopolysaccharide to initiate an innate immune response, and the TRIF-dependent route is one of the signaling outcomes of this engagement. CD14 participates in LPS recognition and influences the subsequent trafficking of the receptor, which is required for the TRIF branch to operate properly.
Receptor internalization and endosomal signaling
In simple terms: After activation, TLR4 moves into the cell, and this move is needed for TRIF to work.
TRIF-dependent signaling is closely tied to TLR4 and CD14 trafficking, and internalization into endosomes is a key step that enables the TRIF adaptor to mediate downstream transduction. Membrane lipid composition also matters: sphingomyelin synthase activity affects TRIF-dependent signaling in cells stimulated with lipopolysaccharide, indicating that the endosomal membrane environment modulates this branch.
TRIF adaptor recruitment and IRF3 activation
In simple terms: Inside the cell, TRIF acts as a relay that switches on interferon-related transcription factors.
The defining feature of GO:0035667 is that TRIF mediates transduction of the signal, distinguishing it from MyD88-dependent TLR4 signaling. Selective TRIF-dependent signaling by a synthetic TLR4 agonist demonstrates that this arm can be activated in a biased manner and leads to downstream responses associated with IRF3 and type I interferon programs.
NF-kB-dependent inflammatory output
In simple terms: The pathway also turns on inflammatory genes, but with different timing and regulation than the MyD88 route.
TRIF-dependent TLR4 signaling contributes to pro-inflammatory signaling downstream of LPS, and its regulation is distinct from the MyD88 arm. In macrophages, MyD88-dependent signaling drives trained immunity, while the TRIF branch represents a parallel and separable route that can be studied independently.
Pharmacological suppression of the TRIF branch
In simple terms: Certain compounds can shut down this specific branch of TLR4 signaling.
CDr10b suppresses the TRIF-dependent signaling pathway of Toll-like receptor in RAW264.7 macrophages, and andrographolide suppresses TRIF-dependent signaling of toll-like receptors by targeting TBK1. These findings show that the pathway contains druggable nodes and can be inhibited without necessarily blocking all TLR4 responses.
Key Genes Involved in GO:0035667 TRIF-dependent toll-like receptor 4 signaling pathway
The following genes and proteins are central to TRIF-dependent TLR4 signaling and are commonly manipulated in research on GO:0035667.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR4 | Pattern recognition receptor that binds LPS and initiates the pathway | Core receptor for GO:0035667 studies; knockout abolishes upstream signaling |
| TICAM1 (TRIF) | Adaptor that defines the TRIF-dependent branch | Defining gene of the pathway; knockout separates TRIF from MyD88 signaling |
| CD14 | Co-receptor that influences LPS recognition and TLR4 trafficking | Required for efficient internalization and TRIF-dependent signaling |
| MYD88 | Adaptor for the parallel MyD88-dependent branch | Used as a comparator to isolate TRIF-specific effects |
| TBK1 | Kinase targeted by andrographolide to suppress TRIF-dependent signaling | Pharmacological node for pathway inhibition |
| IRF3 | Transcription factor associated with TRIF-dependent interferon responses | Readout of TRIF branch activation |
| NFKB1 | Transcription factor mediating inflammatory gene expression | Downstream output of TLR4 signaling |
| SGMS1 | Sphingomyelin synthase enzyme affecting membrane composition | Modulates TRIF-dependent signaling via lipid environment |
| SGMS2 | Sphingomyelin synthase enzyme affecting membrane composition | Modulates TRIF-dependent signaling via lipid environment |
| TRAF3 | Signaling intermediate in TRIF-dependent pathways | Candidate node for CRISPR dissection of the branch |
| TRAF6 | Signaling intermediate in TLR4 pathways | Candidate node for CRISPR dissection of the branch |
| IKBKE | Kinase complex component linked to IRF3 activation | Candidate target for modulating TRIF outputs |
| STAT1 | Interferon signaling transcription factor | Downstream readout of TRIF-dependent interferon production |
| CXCL10 | Interferon-inducible chemokine | Biomarker of TRIF-dependent transcriptional output |
| IFNB1 | Type I interferon gene | Classic readout of TRIF-dependent signaling |
| IL6 | Pro-inflammatory cytokine | Downstream inflammatory readout of TLR4 signaling |
| TNF | Pro-inflammatory cytokine | Downstream inflammatory readout of TLR4 signaling |
| CCL5 | Chemokine associated with inflammatory responses | Candidate readout for pathway modulation |
How Is TRIF-dependent toll-like receptor 4 signaling pathway Regulated?
TRIF-dependent TLR4 signaling is regulated at multiple levels. Receptor trafficking and CD14-dependent internalization control access of TLR4 to the TRIF adaptor, so perturbations in endosomal routing alter pathway output. Membrane lipid composition, including sphingomyelin synthase activity, modulates TRIF-dependent signaling in LPS-stimulated cells. Pharmacological regulation is also well documented: CDr10b suppresses the TRIF-dependent pathway in macrophages, and andrographolide inhibits TRIF-dependent signaling by targeting TBK1. In addition, the balance with MyD88-dependent signaling shapes the overall response, as shown by studies of trained immunity in macrophages.
TRIF-dependent toll-like receptor 4 signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR4 | Neuroinflammation after subarachnoid hemorrhage | TLR4 knockout macrophages and neuronal co-culture |
| TICAM1 (TRIF) | Inflammatory signaling imbalance | TRIF knockout cell line with LPS stimulation |
| CD14 | Defective LPS sensing and trafficking | CD14 knockout macrophages with endosomal trafficking assays |
| TBK1 | Pharmacological suppression of TRIF signaling | TBK1 inhibitor or knockout with andrographolide treatment |
| SGMS1/SGMS2 | Lipid-dependent modulation of TRIF signaling | Sphingomyelin synthase perturbation with LPS stimulation |
Neuroinflammation and brain injury
TLR4 pathway signaling has been proposed as a possible molecular mechanism for brain injuries after subarachnoid hemorrhage, linking this innate immune branch to neuroinflammatory damage. Because TRIF-dependent signaling drives interferon-associated and delayed inflammatory outputs, it is a candidate node for modulating secondary brain injury.
Inflammatory and infectious disease
The TRIF-dependent branch shapes LPS-induced pro-inflammatory signaling, and its trafficking-dependent nature means that defects in CD14 or endosomal routing can alter inflammatory outcomes. Selective activation by a synthetic TLR4 agonist further shows that biased TRIF signaling can be exploited to tune immune responses.
Trained immunity and macrophage reprogramming
Toll-like receptor-induced trained immunity in macrophages is driven by MyD88-dependent signaling, providing a contrast that helps define the specific contribution of the TRIF-dependent branch in innate immune memory. This distinction is relevant for vaccine adjuvant and immunomodulation research.
Pharmacological targeting of TRIF signaling
Small-molecule TLR4 modulators and natural compounds such as CDr10b and andrographolide can suppress TRIF-dependent signaling, supporting drug-discovery efforts aimed at this branch. These tools enable testing whether selective TRIF inhibition is beneficial in inflammatory disease models.
From TRIF-dependent toll-like receptor 4 signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a gene causally drive TRIF-dependent signaling? | CRISPR knockout in a macrophage or monocyte cell line |
| Does a specific residue control adaptor function? | Point-mutation knock-in of the candidate residue |
| Can a tagged adaptor be tracked in endosomes? | Tagged knock-in of TICAM1 (TRIF) |
| Does overexpression amplify TRIF-dependent output? | Overexpression cell model with LPS stimulation |
| Which genes modify the TRIF branch at scale? | CRISPR library screening with interferon or NF-kB reporters |
| Is the MyD88 branch required for a phenotype? | MyD88 knockout compared with TRIF knockout |
How to Study the TRIF-dependent toll-like receptor 4 signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptional changes | Define TRIF-dependent gene programs after LPS |
| Reporter assays | IRF3 or NF-kB activity | Measure pathway activation or inhibition |
| Imaging and trafficking assays | TLR4 and CD14 localization | Test endosomal dependence of TRIF signaling |
| Cytokine ELISA | Secreted inflammatory mediators | Functional readout of pathway activity |
| CRISPR knockout | Loss-of-function causality | Identify genes required for TRIF signaling |
| CRISPR library screening | Pooled gene effects | Discover modifiers of the TRIF branch |
| Lipid perturbation | Membrane composition effects | Test sphingomyelin synthase dependence |
| Pharmacological inhibition | Compound sensitivity | Evaluate TBK1 and other nodes |
Transcriptional profiling of TRIF-dependent outputs
RNA-seq after LPS stimulation in wild-type versus TRIF-deficient cells can define the gene expression program specifically dependent on GO:0035667, including interferon-stimulated genes and inflammatory mediators. Comparing MyD88 knockout and TRIF knockout conditions helps separate the two branches.
Trafficking and imaging assays
Because TRIF-dependent signaling depends on TLR4 and CD14 trafficking, imaging and biochemical fractionation of endosomal compartments are key methods to test pathway activation. Lipid perturbation experiments, such as altering sphingomyelin synthase activity, can be combined with these readouts.
Pharmacological profiling
Small-molecule modulators and natural compounds can be tested for selective effects on TRIF-dependent signaling, using TBK1 targeting and pathway-specific reporters as readouts. Such experiments help distinguish on-pathway from off-target effects.
Functional immune assays
Cytokine and chemokine secretion assays after LPS stimulation provide functional confirmation of TRIF-dependent pathway activity, and trained immunity protocols can reveal interactions with MyD88-dependent programs. These assays are typically paired with genetic perturbation to establish causality.
How CRISPR Can Be Used to Study GO:0035667 TRIF-dependent toll-like receptor 4 signaling pathway
Knockout
CRISPR knockout of TLR4, TICAM1 (TRIF), CD14 or candidate downstream genes provides clean loss-of-function models to test which components are required for GO:0035667. Knockout of TRIF is the definitive way to isolate the TRIF-dependent branch from MyD88-dependent signaling.
Point Mutation
Point-mutation knock-in can be used to test specific residues in TRIF, TBK1 or trafficking regulators for their role in pathway activation. Such models help distinguish structural requirements from mere presence of the protein.
Knock-in
Tagged knock-in of TICAM1 (TRIF) or TLR4 enables tracking of adaptor recruitment and endosomal localization in live cells, directly linking trafficking to TRIF-dependent signaling.
Overexpression
Overexpression of TRIF, TBK1 or IRF3 pathway components can amplify TRIF-dependent outputs and is useful for gain-of-function studies and for testing biased agonists such as synthetic TLR4 agonists.
How EDITGENE Supports TRIF-dependent toll-like receptor 4 signaling pathway Research
Researchers studying TRIF-dependent toll-like receptor 4 signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway output or is merely correlated with it. Establishing causality requires controlled genetic perturbation in a relevant immune cell background, combined with functional readouts such as interferon and cytokine production.
Contact EDITGENE today to design your custom CRISPR model for TRIF-dependent toll-like receptor 4 signaling pathway research.
Frequently Asked Questions About TRIF-dependent toll-like receptor 4 signaling pathway
What is GO:0035667?
GO:0035667 is the TRIF-dependent toll-like receptor 4 signaling pathway, a biological process in which LPS binding to TLR4 triggers intracellular signaling through the TRIF adaptor rather than MyD88.
What is the TRIF-dependent TLR4 signaling pathway?
It is the branch of TLR4 signaling that uses TRIF (TICAM1) to transduce signals, typically linked to endosomal trafficking, IRF3 activation and interferon-related outputs.
What genes are involved in TRIF-dependent toll-like receptor 4 signaling?
Key genes include TLR4, TICAM1 (TRIF), CD14, TBK1, IRF3 and downstream inflammatory mediators, with MYD88 serving as the parallel branch adaptor.
How is TRIF-dependent signaling different from MyD88-dependent signaling?
The two branches use different adaptors: MyD88 drives immediate inflammatory and trained immunity responses, while TRIF mediates a separable route that can be selectively activated by a synthetic TLR4 agonist.
Why does TLR4 need to be internalized for TRIF signaling?
TRIF-dependent signaling is closely tied to TLR4 and CD14 trafficking, and internalization into endosomes is required for the TRIF adaptor to mediate downstream transduction.
Can TRIF-dependent signaling be inhibited pharmacologically?
Yes, compounds such as CDr10b and andrographolide suppress TRIF-dependent signaling, with andrographolide acting by targeting TBK1.
What diseases are linked to TRIF-dependent TLR4 signaling?
The pathway has been linked to neuroinflammation and brain injury after subarachnoid hemorrhage, as well as broader inflammatory and infectious disease contexts.
How do lipids affect TRIF-dependent TLR4 signaling?
Sphingomyelin synthase activity affects TRIF-dependent signaling in cells stimulated with lipopolysaccharide, showing that membrane lipid composition modulates this branch.
What experimental models are used to study GO:0035667?
Common models include CRISPR knockout and knock-in immune cell lines, overexpression systems, reporter assays and pharmacological inhibition with pathway-specific readouts.
Is TRIF-dependent signaling involved in trained immunity?
Trained immunity in macrophages is driven by MyD88-dependent signaling, which provides a contrast for defining the specific contribution of the TRIF-dependent branch.
Conclusion
GO:0035667 provides a precise annotation for the TRIF-dependent arm of TLR4 signaling, a pathway defined by the TRIF adaptor and shaped by receptor trafficking, membrane lipids and pharmacological modulation. Its separable nature from MyD88-dependent signaling makes it an attractive target for causal gene studies and therapeutic exploration in inflammation and neuroinflammation. By combining CRISPR knockout, knock-in, point-mutation and overexpression models with transcriptional and functional readouts, researchers can dissect which genes truly drive TRIF-dependent outputs and which are bystanders.
References
- 1. Ciesielska A et al.. 2021. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling.. Cell Mol Life Sci 78(4):1233-1261 PMID: 33057840
- 2. Bowen WS et al.. 2012. Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist.. Sci Signal 5(211):ra13 PMID: 22337809
- 3. Prymas K et al.. 2020. Sphingomyelin synthase activity affects TRIF-dependent signaling of Toll-like receptor 4 in cells stimulated with lipopolysaccharide.. Biochim Biophys Acta Mol Cell Biol Lipids 1865(2):158549 PMID: 31678513
- 4. Owen AM et al.. 2022. MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages.. Front Immunol 13:1044662 PMID: 36439136
- 5. Lin C et al.. 2021. TLR4 biased small molecule modulators.. Pharmacol Ther 228:107918 PMID: 34171331
- 6. Wang Q et al.. 2020. Toll-like receptor-4 pathway as a possible molecular mechanism for brain injuries after subarachnoid hemorrhage.. Int J Neurosci 130(9):953-964 PMID: 31903827
- 7. Gu GJ et al.. 2015. Suppression of the TRIF-dependent signaling pathway of Toll-like receptor by CDr10b in RAW264.7 macrophages.. Int Immunopharmacol 28(1):29-33 PMID: 26004315
- 8. Kim AY et al.. 2018. Andrographolide suppresses TRIF-dependent signaling of toll-like receptors by targeting TBK1.. Int Immunopharmacol 57:172-180 PMID: 29518743
